Suliqua
| Name | Suliqua |
|---|---|
| Active Substance | insulin glargine / lixisenatide |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| ATC Code | A10AE54 |
| Medicinal product marketed in the Croatia | Da |
| Educational materials for healthcare professionals |
Vodič za zdravstvene readnike, verzija 2 |
| Educational materials for patients / caregivers |
Vodič za bolesnike, verzija 2 |
Note
The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/suliqua
The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm
